Innoviz Technologies (INVZ) grants options and RSUs to chief business officer
Rhea-AI Filing Summary
Innoviz Technologies Ltd. granted Chief Business Officer Elad Ben Hofstetter 57,968 share options on August 4, 2026, each for one ordinary share at an exercise price of $0.42 per share. These options vest one-fourth on August 4, 2027, with the remainder vesting quarterly through 2030, and expire on August 4, 2033.
The company also granted 54,112 Restricted Share Units (RSUs), each a contingent right to one ordinary share with no exercise price, vesting on the same schedule and subject to continued service. After these awards, he directly holds 286,256 ordinary shares, including 176,964 shares issuable upon vesting of multiple RSU grants.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 54,112 shares
Net Buy
2 txns
Insider
Hofstetter Elad Ben
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option F4 | 57,968 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F1, F2, F3 | 54,112 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option — 57,968 shares (Direct);
Ordinary Shares — 286,256 shares (Direct)
Footnotes (4)
- F1. Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
- F2. Includes 176,964 ordinary shares issuable upon vesting of RSUs; of which (a) 1,782 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 7,592 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 10,454 RSUs granted February 27, 2024, with 1,788 vesting quarterly through 2027 and 8,666 vesting quarterly through 2028; (d) 21,087 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 11,341 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 30,804 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 54,112 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.
- F3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- F4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
Key Figures
Share options granted: 57,968 options
Option exercise price: $0.42 per share
RSUs granted: 54,112 RSUs
+3 more
6 metrics
Share options granted
57,968 options
Share options granted on August 4, 2026 to the Chief Business Officer
Option exercise price
$0.42 per share
Exercise price for the 57,968 share options granted August 4, 2026
RSUs granted
54,112 RSUs
Restricted Share Units granted August 4, 2026, vesting through 2030
Ordinary shares after awards
286,256 shares
Direct ordinary share holdings following the reported transactions
RSU-based shares included in holdings
176,964 shares
Ordinary shares issuable upon vesting of RSUs included in post-transaction holdings
Option expiration date
August 4, 2033
Expiration date of the share options granted on August 4, 2026
Key Terms
Restricted Share Units (RSUs), contingent right, exercise price, vesting, +1 more
5 terms
contingent right financial
"Each RSU represents a contingent right to receive one ordinary share"
exercise price financial
"No exercise price is applicable"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
service provider financial
"subject to the Reporting Person remaining a service provider of the Issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity awards did Innoviz Technologies (INVZ) disclose for Elad Ben Hofstetter?
Innoviz Technologies disclosed that Chief Business Officer Elad Ben Hofstetter received 57,968 share options and 54,112 RSUs on August 4, 2026. Both awards vest one-fourth in August 2027, with the remainder vesting quarterly through 2030, subject to continued service.
How many RSUs were granted to the Innoviz Technologies (INVZ) CBO and how do they vest?
He was granted 54,112 Restricted Share Units (RSUs) on August 4, 2026. One-fourth vests on August 4, 2027, and the remaining RSUs vest quarterly through 2030, provided he remains a service provider; each RSU converts into one ordinary share with no exercise price.
What are the terms of the stock options granted by Innoviz Technologies (INVZ) to its CBO?
The CBO received 57,968 share options with an exercise price of $0.42 per share, expiring on August 4, 2033. One-fourth of these options vest on August 4, 2027, and the rest vest quarterly through 2030, conditioned on continued service.
How many RSUs remain outstanding for the Innoviz Technologies (INVZ) CBO from all grants?
Post-transaction, his holdings include 176,964 RSU-linked ordinary shares from multiple grants between 2022 and 2026. These RSUs vest on differing quarterly schedules, with final tranches extending from 2026 through 2030, all subject to continued service with Innoviz Technologies.
Are the Innoviz Technologies (INVZ) equity awards to the CBO subject to conditions?
Yes, both the RSUs and share options vest only if he remains a service provider on each vesting date. The RSUs each deliver one ordinary share without an exercise price, while the options require payment of the $0.42 exercise price per share when exercised.